OXYS CONVERSION AT 52% PREMIUM // OxySure (OXYS) Affiliates

New Post Public Reply Private Reply Replies (0) Message Board

Jan 8, 2013 at 9:28 AM

[b]OXYS >>CONVERSION AT 52% PREMIUM // OxySure (OXYS) Affiliates Convert $2.02 Million in Notes to Common Stock at $1.50 Per Share
Conversion Price represents 52% Premium to Market [/b]

Frisco, Texas, January 3, 2013 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”), the medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that affiliates Agave Resources, LLC and JTR Investments, Limited converted a total of $2,018,656 in convertible notes to OXYS common stock at an aggregate exercise price of $1.50 per common share. The conversion price of $1.50 per share represents a premium of 52% to the OXYS share price at the close of market on January 2, 2013.

Agave Resources converted a subordinated convertible in the amount of $750,000 into 500,000 shares of common stock at a conversion price of $1.50 per share. Don Reed, President of Agave is also a Director of OxySure.

JTR Investments converted a total of $1,268,656 in convertible notes into 845,771 shares of common stock at a conversion price of $1.50 per share, comprising the following: (i) a senior convertible note in the amount of $1,018,656 which was converted into 679,104 shares of common stock; and (ii) a subordinated convertible note in the amount of $250,000 which was converted into 166,667 shares of common stock. Julian Ross, CEO of OxySure is also the President of JTR Management, LLC, the general partner of JTR Investments, Limited.

Said Don Reed, President of Agave: “We are pleased to be able to increase our position in OxySure. This conversion is a testament to our confidence in the company and where we are headed.”

“We are continuing to strengthen our balance sheet in a sensible way, and these conversions represent a significant milestone in that process,” stated Julian Ross, CEO of OxySure. “This step further strengthens our platform for growth as we continue to build our business, while saving thousands of lives.”

About OxySure Systems, Inc.
OxySure Systems, Inc. is a Frisco, Texas-based medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure’s products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments. www.OxySure.com

Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.

Investor Relations Contact(s):                Media Contact:
Chris Castaldo, (516) 656-0217                Yves Dezawy, (646) 546-5151
chriscastaldo@aol.com                    yves@oxysure.com

Chris Hagerman, (208) 361-6624
iradmin@oxysure.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OSL Unveils Instant Redemption for USDGO Plus SP

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

PG&E, Edison Push Liability Cap Amid Firestorm

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Montefiore Einstein Takes On Breast Cancer's Hidden Battle

Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...

Tulsa Hosts Gradient's Global Tech and Investment Event

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Minghui and ASKA Seal Major Licensing Deal for MHB018A

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Cloud Software Group Amends $2B Cash Tender Offer

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Hyundai Pushes Hydrogen Boundaries at 2026 Expo

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Qapture's Institutional Stablecoin Venture Unveiled

Stablecoin Strategy Meets Institutional Investment Here's a fresh one from the digital asset universe. We're talking about Qapture Investments' bold move to launch an institutional-grade stablecoin yield strategy. This ain't your average kitchen table crypto chat—it's the Qapture Safe Haven Vault (QHVN-USD), tailored for those looking to get a better return on their...

Hormel Foods Sets Stage for Q4 Earnings Call in December

Hormel Foods Prepares for Earnings Spotlight In a world where market instability feels like the only constant, Hormel Foods Corporation (NYSE:HRL) is setting up one of those must-watch moments. You've got DECEMBER 3rd circled on your cal, right? If not, you're about to miss a curtain raiser that could send ripples across portfolios. Setting the Stage: December's Big...